Telephone
N/A
Address
2nd Floor 13-15 Bouverie Street Harmsworth House London, Greater London EC4Y 8DP
Description
Doctor Care Anywhere Group PLC is a telehealth company, which engages in delivering care to its patients, whilst reducing the overall cost of providing clinical services. It operates through the following segments: Primary Care, Secondary Care, and Remote Care. The Primary Care segment includes general practice, pharmacy, dental, and optician services. The Secondary Care segment covers medical specialties and levels of clinical acuity, meaning the severity of a patient's illness or condition which determines the level of attention or service they will need from professional staff. The Remote Care segment involves the use of remote medical devices that track patients’ health data and report results automatically. The company was founded by Bayju Thakar and David Jeremy Ravech on February 27, 2014 and is headquartered in London, the United Kingdom.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.1
Trade Value (12mth)
US$1,745.00
1 week
-2.44%
1 month
-15.79%
YTD
6.67%
1 year
25%
All time high
1.52
EPS 3 yr Growth
-72.70%
EBITDA Margin
-6.40%
Operating Cashflow
£0m
Free Cash Flow Return
4.30%
ROIC
-62.20%
Interest Coverage
-3.00
Quick Ratio
1.30
Shares on Issue (Fully Dilluted)
367m
HALO Sector
Healthcare
Next Company Report Date
26-Feb-26
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 April 25 |
Annual General Meeting - Addresses & Presentations
×
Annual General Meeting - Addresses & Presentations |
30 April 25 |
Results of Meeting
×
Results of Meeting |
28 April 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
15 April 25 |
Change of Address of Registered Office in Australia
×
Change of Address of Registered Office in Australia |
02 April 25 |
Notice of Annual General Meeting/CDI Voting Instruction
×
Notice of Annual General Meeting/CDI Voting Instruction |
01 April 25 |
Change of Director's Interest Notice - Laura O'Riordan
×
Change of Director's Interest Notice - Laura O'Riordan |
31 March 25 |
Appendix 4G
×
Appendix 4G |
31 March 25 |
2024 Annual Report & Corporate Governance Statement
×
2024 Annual Report & Corporate Governance Statement |
27 March 25 |
Notification regarding unquoted securities - DOC
×
Notification regarding unquoted securities - DOC |
24 March 25 |
Response to ASX Price Query
×
Response to ASX Price Query |
24 March 25 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
21 March 25 |
Pause in Trading
×
Pause in Trading |
21 March 25 |
Suspension from Quotation
×
Suspension from Quotation |
27 February 25 |
Appendix 4E FY24 Preliminary Final Report
×
Appendix 4E FY24 Preliminary Final Report |
27 February 25 |
Investor Presentation FY24 Results
×
Investor Presentation FY24 Results |
20 February 25 |
Doctor Care Anywhere Launches Investor Hub
×
Doctor Care Anywhere Launches Investor Hub |
12 February 25 |
Change in substantial holding from TEK
×
Change in substantial holding from TEK |
12 February 25 |
Change in substantial holding from Tiga Trading Pty Ltd
×
Change in substantial holding from Tiga Trading Pty Ltd |
06 February 25 |
Preliminary final report release date
×
Preliminary final report release date |
30 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 January 25 |
Appointment of Non-Executive Director - Prof Sam Shah
×
Appointment of Non-Executive Director - Prof Sam Shah |
29 January 25 |
Initial Director's Interest Notice - Prof Sam Shah
×
Initial Director's Interest Notice - Prof Sam Shah |
23 January 25 |
Quarterly Activity Report release date announcement
×
Quarterly Activity Report release date announcement |
07 January 25 |
Initial Director's Interest Notice - Laura O'Riordan
×
Initial Director's Interest Notice - Laura O'Riordan |
07 January 25 |
Final Directors' Interest Notices - Kent Spencer Abdin
×
Final Directors' Interest Notices - Kent Spencer Abdin |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.